Grand Hospital of Charleroi integrates IMAgo4D for RT adaptive contouring
- December 7, 2018
Grand Hospital of Charleroi – Gilly Center (Belgium) integrates IMAgo4D solution into its radiotherapy treatment planning process. Robust, dynamic and adaptable, the solution can support 4D image series and take the patient’s anatomy changes into account during the treatment session. It helps the center to perform contouring tasks more efficiently on the various respiratory phases.
[AuntMinnie.com] DOSIsoft gets FDA OK for ThinkQA-EPIbeam, updates Planet Dose
- December 3, 2018
Radiation oncology and nuclear medicine software provider DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ThinkQA-EPIbeam modular software suite and has also launched an updated version of its Planet Dose dosimetry system for molecular radiotherapy.
[Abstract] 60 Comparison of organ-based absorbed doses estimations by using PLANET Dose and OLINDA/EXM V2.0 in patients with peptide receptor radionuclide therapy (PRRT) treated with Lutathera
- December 1, 2018
E. Mora-Ramirez, E. Cassol, L. Santoro, S. Chouaf, D. Trauchessec, J. Pouget, P. Kotzki, E. Deshayes, M. Bardiès
Physica Medica 56 (2018) 1–39 doi.org/10.1016/j.ejmp.2018.09.073
[SIH-Solutions Magazine] La sécurisation du parcours de soin du patient en radiothérapie
- November 23, 2018
How DOSIsoft optimizes patient’s safety in Radiation Therapy. Discover experimentation results of “EPIbeam” quality assurance Solution published in SIH-Solutions Magazine.
[PhD Thesis] Contrôle de la dose délivrée en radiothérapie externe : Etude de l’apport mutuel de l’imagerie volumique embarquée et de la dosimétrie de transit*
- November 17, 2018
*Control of the dose delivered in external radiotherapy : study of the mutual contribution of on-board volume imaging and transit dosimetry
Work in collaboration with DOSEO and The Institut Curie
PhD Thesis completed on November 16th 2018 by Clément Chevillard
In November, DOSIsoft supports Personalized Medicine Awareness Month 2018
- November 15, 2018
During Personalised Medicine Awareness Month-November 2018, DOSIsoft is proud to get involved and support the initiative launched by the European Cancar Patient Coalition (ECPC).
Great collaboration with Panacea Medical Technologies at AMPICON 2018
- November 13, 2018
The 39th Annual Conference of Association of Medical Physicists of India (AMPICON 2018) was held from 2 to 4 November, 2018 at Chennai Trade Center under the topic of “Medical Physics: Redefining Dosimetry”.
DOSIsoft was proud of the partnership with Panacea Medical Technologies to unveil the “All-in-One” Accurate Treatment Planning System (TPS) – ISOgray®.
DOSIsoft joins in the celebration of the 6th International Day of Medical Physics (IDMP)
- November 7, 2018
Spin-off from Institut Gustave Roussy and Institut Curie, DOSIsoft is delighted to celebrate the 6th IDMP on November 7, 2018 around the theme ‘Medical Physics for Patient Benefit’ and 151st birthday of Marie Curie. As a leading and important Medical Physics player, we work always on Medical Imaging & Dosimetry software dedicated to help improve the quality and precision of cancer treatment by Radiotherapy.
Launching new version of PLANET® Dose: CE marked Multi-radionuclide 3D Personalized Dosimetry Platform for Molecular Radiotherapy
- October 12, 2018
DOSIsoft launches a new version of PLANET® Dose – its multi-radionuclide dosimetry platform dedicated to Molecular Radiotherapy (MRT). In addition to improvements for 90Yttrium-based therapies, the new version includes the full support of 177Lutetium-based therapies. These additional developments have been performed in collaboration with the Cancer Research Center of Toulouse (CRCT) – UMR 1037 Inserm / Toulouse III – Paul Sabatier University and the Institut Jules Bordet in Brussels.
Regina Elena Hospital Purchases PLANET Software Suite
- October 5, 2018
Warm welcome to Regina Elena Hospital (Rome, Italy) who decided to purchase PLANET® Dose/Onco to perform multimodal imaging management and better personalize 3D dosimetry-based treatment planning and in vivo control.